Is CRISPR safe? Genome editing gets its first FDA scrutiny :

Advisors to the US regulatory agency will examine the safety profile of a CRISPR-based treatment for sickle-cell disease. Advisors to the US regulatory agency will examine the safety profile of a CRISPR-based treatment for sickle-cell disease.

Related Keywords

San Marcos , California , United States , Cambridge , Cambridgeshire , United Kingdom , Boston , Massachusetts , Tennessee , Memphis , Pennsylvania , Switzerland , San Francisco , Mark Walters , Meletios Verras Getty , Tosin Ola , Samira Kiani , Akshay Sharma , University Of Pittsburgh School Medicine , University Of California , Jude Children Research Hospital In Memphis , Shell , Vertex Pharmaceuticals , Drug Administration , Pittsburgh School , Jude Children , Research Hospital , Bluebird Bio , Sickle Cell Warriors ,